Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 31.21.
Forward PE Ratio (31.21) = Close Price ($93.04) / Consensus Forward EPS ($3.00)
FORWARD PE RATIO
31.21
SECTOR MEDIAN · HEALTHCARE
19.90
median of 67 covered companies
CURRENT VS SECTOR MEDIAN
+56.83%
vs the sector median at left
Edwards Lifesciences Corporation
Market Cap
$53.57B
Forward PE Ratio
31.21
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Edwards Lifesciences Corporation (EW) | $53.57B | 31.21 |
| Cardinal Health, Inc. (CAH)vs › | $54.85B | 19.90 |
| Becton, Dickinson and Company (BDX)vs › | $50.56B | 14.39 |
| Humana Inc. (HUM)vs › | $46.68B | 40.74 |
| Cencora, Inc. (COR)vs › | $61.12B | 18.74 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $45.01B | 39.83 |
| Agilent Technologies, Inc. (A)vs › | $41.88B | 24.68 |
| IQVIA Holdings Inc. (IQV)vs › | $39.81B | 18.81 |
| DexCom, Inc. (DXCM)vs › | $34.27B | 33.69 |
| Cigna Corporation (CI)vs › | $73.29B | 8.99 |
Trailing P/E
53.8
reported TTM EPS
Forward P/E
31.2
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $3.00 implies +72.4% EPS growth vs the reported trailing $1.74.
At today's $93.04 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $3.00 | $2.97 – $3.02 | 16 | 31.0x |
| 2027-12-31 | $3.38 | $3.29 – $3.46 | 16 | 27.5x |
| 2028-12-31 | $3.80 | $3.67 – $3.89 | 8 | 24.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
